New Vaccines Target PED
Wed Oct 1, 2014 03:33 PM CDT

(Dow Jones) -- Drug companies are racing to create vaccines to stifle a deadly swine virus that has roiled the U.S. meat industry and pushed pork prices to record highs.

Two companies -- tiny Harrisvaccines Inc. and larger animal-health firm Zoetis Inc. -- received conditional regulatory approval this summer to market vaccines for porcine epidemic diarrhea virus, which has spread to 31 states and killed millions of young pigs since it was first identified in the U.S. in April 2013. At least two other drug makers -- Merck & Co. and Germany's Boehringer Ingelheim GmbH -- say they are researching ...

Quick View
Related News Stories
Mo. Farmer Builds Methane Production
Import Tariffs Anger Pork Industry
Study Confirms Feed-PED Risk
CME Plans Hog Futures Changes